Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matilde Inglese

Showing results (221-230 of 315) with videos related to

Pageof 32
Sort By:
La Medicina Del Lavoro|June 26, 2024
Occupational Physicians' Management of Workers With Multiple Sclerosis in Italy: Results From a SurveyBruna Maria Rondinone, Giuliana Buresti, Sergio Iavicoli, et al.
Brain Sciences|April 3, 2021
Public Engagement and Neurology: An UpdateLuigi Lavorgna, Francesco Brigo, Sabrina Esposito, et al.
Journal of Neurology|May 4, 2024
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched studyAurora Zanghì, Giovanna Borriello, Simona Bonavita, et al.
Frontiers in Immunology|November 16, 2020
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple SclerosisTatiana Koudriavtseva, Annunziata Stefanile, Marco Fiorelli, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 29, 2022
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 PandemicAurora Zanghì, Carlo Avolio, Elisabetta Signoriello, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 11, 2022
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With OcrelizumabDoriana Landi, Alfonso Grimaldi, Francesca Bovis, et al.
Brain : a Journal of Neurology|July 16, 2019
A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosisMaureen Wentling, Carlos Lopez-Gomez, Hye-Jin Park, et al.
Frontiers in Immunology|August 16, 2023
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosisTatiana Koudriavtseva, Svetlana Lorenzano, Maria Cellerino, et al.
JMIR Research Protocols|February 3, 2025
Effect of an Internet-Based Pilates Telerehabilitation Intervention in People With Multiple Sclerosis: Protocol for a Randomized Controlled TrialAndrea Tacchino, Michela Ponzio, Paolo Confalonieri, et al.
Plos One|February 27, 2025
Study protocol: Exploratory trial of Forza™, an osmotin-based nutraceutical as adjuvant for the treatment of progressive multiple sclerosisViola Costa, Kenda Aluan, Irene Schiavetti, et al.
Pageof 32

Showing results (221-230 of 315) with videos related to

Sort By:
Pageof 32
La Medicina Del Lavoro|June 26, 2024
Occupational Physicians' Management of Workers With Multiple Sclerosis in Italy: Results From a SurveyBruna Maria Rondinone, Giuliana Buresti, Sergio Iavicoli, et al.
Brain Sciences|April 3, 2021
Public Engagement and Neurology: An UpdateLuigi Lavorgna, Francesco Brigo, Sabrina Esposito, et al.
Journal of Neurology|May 4, 2024
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched studyAurora Zanghì, Giovanna Borriello, Simona Bonavita, et al.
Frontiers in Immunology|November 16, 2020
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple SclerosisTatiana Koudriavtseva, Annunziata Stefanile, Marco Fiorelli, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 29, 2022
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 PandemicAurora Zanghì, Carlo Avolio, Elisabetta Signoriello, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 11, 2022
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With OcrelizumabDoriana Landi, Alfonso Grimaldi, Francesca Bovis, et al.
Brain : a Journal of Neurology|July 16, 2019
A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosisMaureen Wentling, Carlos Lopez-Gomez, Hye-Jin Park, et al.
Frontiers in Immunology|August 16, 2023
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosisTatiana Koudriavtseva, Svetlana Lorenzano, Maria Cellerino, et al.
JMIR Research Protocols|February 3, 2025
Effect of an Internet-Based Pilates Telerehabilitation Intervention in People With Multiple Sclerosis: Protocol for a Randomized Controlled TrialAndrea Tacchino, Michela Ponzio, Paolo Confalonieri, et al.
Plos One|February 27, 2025
Study protocol: Exploratory trial of Forza™, an osmotin-based nutraceutical as adjuvant for the treatment of progressive multiple sclerosisViola Costa, Kenda Aluan, Irene Schiavetti, et al.
Pageof 32